LMH STRATEGIC SOLUTIONS

Lobbying for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA) · Represents and protects the interests of midsized biopharmaceutical innovators.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $230,000.00 income · posted Jul 5, 2026

Lobbying activity 2

Pharmacy

Prescription drug payment reform. Pharmaceutical Supply Chain.

Medicare/Medicaid

General Medicare and Medicaid Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.